The DOI matches its Crossref record; 54 of the 55 references it cites were found in a registry or an index.
Alterations of the Intestinal Barrier in Patients With Autism Spectrum Disorders and in Their First‐degree Relatives
Abstract
Objectives Intestinal permeability (IPT) was investigated in patients with autism as well as in their first-degree relatives to investigate leaky gut hypothesis. Faecal calprotectin (FC) was also measured in patients with autism, either with or without gastrointestinal symptoms, and in their first-degree relatives. Patients and methods IPT results, assessed by means of the lactulose/mannitol test, were compared with adult and child controls and with FC values. Results A high percentage of abnormal IPT values were found among patients with autism (36.7%) and their relatives (21.2%) compared with normal subjects (4.8%). Patients with autism on a reported gluten-casein-free diet had significantly lower IPT values compared with those who were on an unrestricted diet and controls. Gastrointestinal symptoms were present in 46.7% of children with autism: constipation (45.5%), diarrhoea (34.1%), and others (alternating diarrhoea/constipation, abdominal pain, etc: 15.9%). FC was elevated in 24.4% of patients with autism and in 11.6% of their relatives; it was not, however, correlated with abnormal IPT values. Conclusions The results obtained support the leaky gut hypothesis and indicate that measuring IPT could help to identify a subgroup of patients with autism who could benefit from a gluten-free diet. The IPT alterations found in first-degree relatives suggest the presence of an intestinal (tight-junction linked) hereditary factor in the families of subjects with autism.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Offspring from the poly (I:C) mouse model of MIA exhibit gastrointestinal changes that are also found in some humans with ASD155,156, including increased intestinal permeability and abnormal intestinal cytokine profiles157.”
From Immune mediators in the brain and peripheral tissues in autism spectrum disorder (2015) · cites this paper as [156]
In the citing paper
“In the case of impaired BBB, which can be observed in certain (but not all) autistic subjects [37,254], LPS or SCFAs may cause brain inflammation and thus, further facilitate access to the brain for harmful substances, like heavy metals, that can accumulate there [228,246,255].”
From The Role of Microbiota-Gut-Brain Axis in Neuropsychiatric and Neurological Disorders (2021) · cites this paper as [254]
In the citing paper
“Along with altered bowel habits, ASD has been associated with impaired intestinal barrier function (D'Eufemia et al., 1996; de Magistris et al., 2010; Fiorentino et al., 2016).”
From Microbiota-related Changes in Bile Acid & Tryptophan Metabolism are Associated with Gastrointestinal Dysfunction in a Mouse Model of Autism (2017) · cites this paper as de Magistris et al., 2010
In the citing paper
“Many ASD children have also been shown to carry abnormalities in GI physiology, including: increased intestinal permeability [34,35], overall microbiota alterations [36,37,38,39,40], and gut infection with cresol-producing Clostridium difficile [39,41,42,43,44].”
From Autism, Gastrointestinal Symptoms and Modulation of Gut Microbiota by Nutritional Interventions (2019) · cites this paper as [35]
In the citing paper
“Intestinal dysbiosis is often associated, in the ASD population, with an alteration of the barrier of the intestinal mucosa with consequent increase of the intestinal permeability to exogenous substances of alimentary or bacterial origin, in some cases even neurotoxic [35].”
From Autism, Gastrointestinal Symptoms and Modulation of Gut Microbiota by Nutritional Interventions (2019) · cites this paper as [35]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
2 retracted
Gluten- and casein-free diets for autistic spectrum disorder
Millward, C., Ferriter, M., Calver, S. J., & Connell-Jones, G. G. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003498.pub3 · Cited by 274
RetractedGluten- and casein-free diets for autistic spectrum disorder
Ferriter, M., Calver, S. J., Connell-Jones, G. G., & Millward, C. (2001) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003498 · Cited by 27
RetractedLord, C., Rutter, M., & Le Couteur, A. (1994) · Journal of Autism and Developmental Disorders · doi:10.1007/bf02172145 · Cited by 9,065 · cited 1×
“All of the children were administered the Autism Diagnostic Interview-Revised version (23), the Childhood Autism Rating Scales (24), and the Autism Diagnostic Observation Schedule-Generic (25) to document the diagnosis of autism.”
MethodToward objective classification of childhood autism: Childhood Autism Rating Scale (CARS)
Schopler, E., Reichler, R. J., DeVellis, R. F., & Daly, K. (1980) · Journal of Autism and Developmental Disorders · doi:10.1007/bf02408436 · Cited by 2,432 · cited 1×
“All of the children were administered the Autism Diagnostic Interview-Revised version (23), the Childhood Autism Rating Scales (24), and the Autism Diagnostic Observation Schedule-Generic (25) to document the diagnosis of autism.”
MethodIntestinal permeability: an overview
Bjarnason, I., Macpherson, A., & Hollander, D. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90708-4 · Cited by 927 · cited 2×
“IPT, as measured by the urinary excretion of metabolically inert sugars after oral dosing, is a surrogate marker of mucosal integrity (16) and of gut barrier function.”
BackgroundBuie, T., Campbell, D. B., Fuchs, G. J., Furuta, G. T., Levy, J., VandeWater, J., Whitaker, A. H., Atkins, D., Bauman, M. L., Beaudet, A. L., et al. (2010) · Pediatrics · doi:10.1542/peds.2009-1878c · Cited by 872 · cited 2×
“The precise role or frequency of increased paracellular permeability in children with ASD, as well as its correlation with the various clinical and behavioural aspects of ASD, remain unclear (5).”
BackgroundAssessment of the Neutrophil Dominating Protein Calprotectin in Feces: A Methodologic Study
RØseth, A. G., Fagerhol, M. K., Aadland, E., & Schjønsby, H. (1992) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529209011186 · Cited by 669 · cited 1×
“Normal values were estimated to be <100 mg/g stool (adult and children) on the basis of previous reports (28,29) and our own laboratory experience.”
BackgroundLammers, K. M., Lu, R., Brownley, J., Lu, B., Gerard, C., Thomas, K., Rallabhandi, P., Shea-Donohue, T., Tamiz, A., Alkan, S., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.03.023 · Cited by 540 · cited 1×
“The influence of environment (ie, ‘‘toxic’’ gluten) (35,51) on the intestinal barrier is also suggested.”
BackgroundIdentification of human zonulin, a physiological modulator of tight junctions, as prehaptoglobin-2
Tripathi, A., Lammers, K. M., Goldblum, S., Shea-Donohue, T., Netzel-Arnett, S., Buzza, M. S., Antalis, T. M., Vogel, S. N., Zhao, A., Yang, S., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906773106 · Cited by 443 · cited 1×
“The influence of environment (ie, ‘‘toxic’’ gluten) (35,51) on the intestinal barrier is also suggested.”
BackgroundTibble, J. A., Sigthorsson, G., Foster, R., Forgacs, I., & Bjarnason, I. (2002) · Gastroenterology · doi:10.1053/gast.2002.34755 · Cited by 441 · cited 1×
“Even though the possibility of day-to-day FC variations exists (48), our findings are in keeping with previous reports (49) and do not confirm those by Tibble et al (50).”
Result
Research works printed but not linked: 2
- Turck D, 2008, Walker's Pediatric Gastroenterologic Diseases: Pathophysiology, Diagnosis, Management
- 10.1097/00005176-200107000-00003 · doi:10.1097/00005176-200107000-00003 · Paper page
Cited by
Hsiao, E. Y., McBride, S. W., Hsien, S., Sharon, G., Hyde, E. R., McCue, T., Codelli, J. A., Chow, J., Reisman, S. E., Petrosino, J. F., et al. (2013) · Cell · doi:10.1016/j.cell.2013.11.024 · Cited by 3,283
“We utilize the maternal immune activation (MIA) model, which is based on large epidemiological studies linking maternal infection to increased autism risk in the offspring (Atladó ttir et al., 2010; Gorrindo et al., 2012).”
The Oslo definitions for coeliac disease and related terms
Ludvigsson, J. F., Leffler, D. A., Bai, J. C., Biagi, F., Fasano, A., Green, P. H. R., Hadjivassiliou, M., Kaukinen, K., Kelly, C. P., Leonard, J. N., et al. (2013) · Gut · doi:10.1136/gutjnl-2011-301346 · Cited by 1,721
The intestinal barrier: a fundamental role in health and disease
Vancamelbeke, M., & Vermeire, S. (2017) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2017.1343143 · Cited by 1,287
“with abnormal intestinal permeability values [43,44].”
Spectrum of gluten-related disorders: consensus on new nomenclature and classification
Sapone, A., Bai, J. C., Ciacci, C., Dolinsek, J., Green, P. H., Hadjivassiliou, M., Kaukinen, K., Rostami, K., Sanders, D. S., Schumann, M., et al. (2012) · BMC Medicine · doi:10.1186/1741-7015-10-13 · Cited by 1,140
“Through the years, a GFD has been experimentally applied to schizophrenia, multiple sclerosis, ASD and dementia, to name only a few instances.”
BackgroundSelf-citationKelly, J. R., Kennedy, P. J., Cryan, J. F., Dinan, T. G., Clarke, G., & Hyland, N. P. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00392 · Cited by 1,110
“…permeability Preclinical Moussaoui et al., 2014 FECAL MARKERS Calprotectin Feces Nonspecific marker of gut inflammation Clinical and preclinical de Magistris et al., 2010 Zonulin Feces Marker of intestinal permeability Clinical Lamprecht et al., 2012 EX VIVO Ussing chamber Ex vivo biopsies…”
Background
Metadata
- Authors
- de Magistris, L., Familiari, V., Pascotto, A., Sapone, A., Frolli, A., Iardino, P., Carteni, M., De Rosa, M., Francavilla, R., Riegler, G., Militerni, R., & Bravaccio, C.
- Affiliations
- Department Magrassi‐Lanzara Gastroenterology Italy
- Department of Psychiatry, Neuropsychiatry, Dermatovenereology Italy
- University of Campania "Luigi Vanvitelli" (IT)
- Department of Experimental Medicine Italy
- University of Bari Aldo Moro (IT)
- Federico II University Hospital (IT)
- Corresponding author
- de Magistris, Laura
- Familiari, Valeria
- Sapone, Anna
- Riegler, Gabriele
- Venue
- Journal of Pediatric Gastroenterology and Nutrition
- Publisher
- Wiley
- Published
- 2010-10
- Volume
- 51
- Issue
- 4
- Pages
- 418-424
- ISSN
- 0277-2116 (ISSN-L)
- 1536-4801
- OpenAlex
- W2046831320
- Cited by
- 546
- References
- 55
- Citations by year
- 2026: 18 · 2025: 33 · 2024: 31 · 2023: 31 · 2022: 36 · 2021: 58 · 2020: 48 · 2019: 43 · 2018: 49 · 2017: 28 · 2016: 36 · 2015: 30 · 2014: 28 · 2013: 35 · 2012: 27
- FWCI
- 14.74
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Pediatric Gastroenterology and Nutrition (publishedVersion)
- PubMed (publishedVersion)
- Archivio Istituzionale della Ricerca - Università degli Studi della Campania "Luigi Vanvitelli" (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Health Sciences › Medicine › Psychiatry and Mental health › Child Nutrition and Feeding Issues
- Keywords
- autism spectrum disorder, intestinal permeability, fecal calprotectin, lactulose/mannitol test, gluten-free diet, gastrointestinal symptoms, constipation, diarrhea, first-degree relatives, tight junctions
- MeSH terms
- Analysis of Variance, Child, Child Development Disorders, Pervasive, Constipation, Diarrhea, Enzyme-Linked Immunosorbent Assay, Family, Feces, Female, Humans, Inflammation, Intestinal Diseases, Intestinal Mucosa, Italy, Male, Permeability, Abdominal Pain, Comorbidity, Leukocyte L1 Antigen Complex
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Alterations of the Intestinal Barrier in Patients With Autism Spectrum Disorders and in Their First‐degree Relatives. https://app.cochat.ai/papers/10.1097/mpg.0b013e3181dcc4a5
- The paper
- de Magistris, L., Familiari, V., Pascotto, A., Sapone, A., Frolli, A., Iardino, P., Carteni, M., De Rosa, M., Francavilla, R., Riegler, G., Militerni, R., & Bravaccio, C. (2010). Alterations of the Intestinal Barrier in Patients With Autism Spectrum Disorders and in Their First‐degree Relatives. Journal of Pediatric Gastroenterology and Nutrition. https://doi.org/10.1097/mpg.0b013e3181dcc4a5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.